Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Apr 04, 2024 $17.05 $17.51 $16.48 $16.58 774 667
Apr 03, 2024 $17.20 $17.45 $16.75 $17.15 747 156
Apr 02, 2024 $17.67 $17.79 $17.24 $17.25 752 564
Apr 01, 2024 $18.71 $18.76 $17.80 $17.90 666 596
Mar 28, 2024 $19.06 $19.34 $18.51 $18.74 885 054
Mar 27, 2024 $18.80 $19.19 $18.71 $19.04 499 478
Mar 26, 2024 $19.25 $19.25 $18.42 $18.62 788 736
Mar 25, 2024 $19.16 $19.52 $18.60 $18.69 523 279
Mar 22, 2024 $20.23 $20.32 $19.18 $19.22 427 171
Mar 21, 2024 $19.78 $20.28 $19.27 $19.97 756 291
Mar 20, 2024 $19.09 $19.74 $18.87 $19.68 668 400
Mar 19, 2024 $19.33 $19.67 $19.04 $19.28 848 271
Mar 18, 2024 $20.09 $20.09 $18.96 $19.37 1 189 971
Mar 15, 2024 $20.01 $20.77 $19.83 $19.97 1 572 365
Mar 14, 2024 $20.39 $20.54 $19.71 $19.81 751 610
Mar 13, 2024 $20.07 $20.90 $20.07 $20.61 967 999
Mar 12, 2024 $21.05 $21.20 $20.25 $20.35 617 144
Mar 11, 2024 $21.79 $22.18 $21.07 $21.18 706 628
Mar 08, 2024 $21.76 $22.34 $21.60 $22.09 596 577
Mar 07, 2024 $21.25 $21.79 $20.94 $21.37 611 346
Mar 06, 2024 $21.50 $21.65 $21.03 $21.13 865 921
Mar 05, 2024 $21.96 $21.97 $21.17 $21.23 813 839
Mar 04, 2024 $22.00 $22.14 $21.48 $21.77 678 955
Mar 01, 2024 $21.62 $22.17 $21.42 $21.86 803 586
Feb 29, 2024 $22.97 $23.00 $21.41 $21.48 909 620
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT